本研究报道了 2019 年 7 月 1 日于南昌大学第一附属医院行达芬奇 Xi 机器人辅助充气式纵隔镜食管癌切除术 1 例。患 者为老年男性，因“进行性吞咽困难 2 个月”就诊。入院后行电子胃镜检查并取活检，活检病理提示食管鳞状细胞癌。完善 术前检查后，行机器人辅助充气式纵隔镜食管癌切除术，手术顺利，手术时间共计395 min，术中失血约150 mL，术后恢复良好， 患者于术后第 6 天顺利康复出院，术后 1 个月内未出现声音嘶哑、吻合口瘘等并发症。

The First Affiliated Hospital of Nanchang University conducted a Da Vinci Xi robot-assisted inflatable mediastinoscopic esophagectomy on July 1, 2019. An old man with “progressive dysphagia for 2 months” arrived at the hospital. Electronic gastroscopy and biopsy were performed on the patient after admission, and the pathology revealed squamous cell carcinoma of the esophagus. After completing the preoperative examination, robot-assisted inflatable mediastinoscopic esophagectomy was performed. The operation went smoothly, with a total operative time of 395 min and intraoperative blood loss of about 150 mL. The patient had a good postoperative recovery and was discharged from the hospital on the 6th day after surgery, with no complications such as hoarseness and anastomotic fistula within 1 month after surgery.

基金项目：江西省卫生健康委科技计划（202210404，202130304） 

Foundation Item: Science and Technology Program of Jiangxi Provincial Health and Wellness Commission (202210404, 202130304) 

引用格式：杨超，邹国稳，蒋磊，等 . 达芬奇 Xi 机器人辅助充气式纵隔镜食管癌切除术一例报道（附手术视频）[J]. 机器人外科学杂志（中 英文），2025，6（4）：695-700. 

Citation: YANG C, ZOU G W, JIANG L, et al. Da Vinci Xi robot-assisted inflatable mediastinoscopic esophagectomy: a case report (with  surgical video) [J]. Chinese Journal of Robotic Surgery, 2025, 6(4): 695-700. 

通讯作者（Corresponding Author）：喻本桐（YU Bentong），Email：bentongyu@163.com

[1] Sung H, Ferlay J, Siegel R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. 

[2] DENG H Y, LUO J, LI S X, et al. Does robot-assisted minimally invasive esophagectomy really have the advantage of lymphadenectomy over video-assisted minimally invasive esophagectomy in treating esophageal squamous cell carcinoma? A propensity score-matched analysis based on short-term outcomes[J]. Dis Esophagus, 2019, 32(7): doy110. 

[3] 王谦 , 刘慧兵 , 张鲁昌 , 等 . 单孔充气式纵隔镜辅助经裂孔食管切除术 与功能性微创食管癌切除术治疗食管癌的倾向性评分匹配研究 [J]. 中国胸心血管外科临床杂志 , 2024, 31(11): 1625-1631.

[4] 中华医学会消化病学分会胃肠动力学组 , 胃肠功能性疾病协作组 , 食管疾病协作组 . 中国贲门失弛缓症诊疗规范 [J]. 中华消化杂志 , 2023, 43(10): 657-664. 

[5] Ahmadi N, Crnic A, Seely A J, et al. Impact of surgical approach on perioperative and long-term outcomes following esophagectomy for esophageal cancer[J]. Surg Endosc, 2018, 32(4): 1892-1900. 

[6] Buess G, Becker H D. Minimally invasive surgery in tumors of the esophagus[J]. Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir, 1990: 1355-1360. 

[7] Fujiwara H, Shiozaki A, Konishi H, et al. Single-port mediastinoscopic lymphadenectomy along the left recurrent laryngeal nerve[J]. Ann Thorac Surg, 2015, 100(3): 1115-1117. 

[8] 吴汉然 , 柳常青 , 解明然 . 充气式纵隔镜食管癌切除术中国专家共 识 [J]. 中国胸心血管外科临床杂志 , 2023, 30(10): 1367-1376. 

[9] 李刚 , 张嘉妮 , 沈旭 , 等 . 达芬奇机器人辅助与胸腹腔镜辅助微创食 管癌切除术临床效果的系统评价与 Meta 分析 [J]. 中国胸心血管外科 临床杂志 , 2022, 29(9): 1181-1188. 

[10] 杨俊 . 改良充气式纵隔镜在早期胸段食管癌中的临床应用 [J]. 当代 医学 , 2021, 27(29): 172-173. 

[11] Melvin W S, Needleman B J, Krause K R, et al. Computer-enhanced robotic telesurgery[J]. Surg Endosc, 2002, 16(12): 1790-1792. 

[12] Protyniak B, Jorden J, Farmer R. Multiquadrant robotic colorectal surgery: the Da Vinci Xi vs Si comparison[J]. J Robot Surg, 2018, 12(1): 67-74. 

[13] 宋伟安 , 刘军强 , 岳彩迎 , 等 . 机器人辅助微创食管切除术治疗食管 癌 12 例分析 [J]. 转化医学杂志 , 2019, 8(5): 311-313. 

[14] 毕卫云 , 朱财林 , 李朗 , 等 . 利用达芬奇机器人手术模拟训练器 开展临床技能培训的探讨 [J]. 医学教育研究与实践 , 2019, 27(6): 1098-1101. 

[15] 曹莉莉 , 徐惠成 , 陈勇 , 等 . 达芬奇机器人手术系统在宫颈癌广泛 子宫切除手术中学习曲线的研究 [J]. 实用妇产科杂志 , 2015, 31(9): 705-708. 

[16] 陈硕 , 游宾 , 李辉 . 解读食管癌根治术胸部淋巴结清扫中国专家共识 (2017 版 ) 中食管癌胸部区域淋巴结清扫基于淋巴结数目或分组 [J]. 中华肿瘤杂志 , 2019, 41(1): 73-76. 

[17] 罗文卿 , 李源奇 , 叶飞 , 等 . 胸段食管鳞癌喉返神经旁淋巴结转移 风险预测模型的构建 [J]. 中华实用诊断与治疗杂志 , 2022, 36(5): 463-467. 

[18] 李宾 , 王忠民 , 曹克鑫 , 等 . 微创食管癌术后淋巴结转移情况对预后 的影响研究 [J]. 实用肿瘤杂志 , 2020, 35(2): 154-158. 

[19] GAN X F, ZHONG H C, LI X J, et al. Mediastinal lymphadenectomy under laparoscopic assisted single-port inflatable mediastinoscopy through left neck approach[J]. Transl Cancer Res, 2020, 9(8): 4976-4981. 

[20] YU S F, ZHANG W C, NI W J, et al. A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage Ⅲ esophageal squamous cell carcinoma after R0 esophagectomy[J]. Radiother Oncol, 2019, 140: 159-166. 

[21] ZHANG L Z, LI W W, LYU X, et al. Adjuvant chemotherapy with paclitaxel and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma[J]. Chin J Cancer Res, 2017, 29(2): 149-155. 

[22] Kelly R J, Ajani J A, Kuzdzal J, et al. Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer[J]. N Engl J Med, 2021, 384(13): 1191-1203.

[23] Ajani J A, D’Amico T A, Bentrem D J, et al. Esophageal and esophagogastric junction cancers, version 2.2023, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2023, 21(4): 393-422.